Tetsuo Iida Selected Research

psicose (D-psicose)

1/2022	d-Allulose Improves Endurance and Recovery from Exhaustion in Male C57BL/6J Mice.
1/2022	d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes.
10/2021	d-Allulose Ameliorates Skeletal Muscle Insulin Resistance in High-Fat Diet-Fed Rats.
9/2021	Investigation of d-allulose effects on high-sucrose diet-induced insulin resistance via hyperinsulinemic-euglycemic clamps in rats.
5/2021	Effect of D-allulose feeding on the hepatic metabolomics profile in male Wistar rats.
4/2020	D-Allulose enhances uptake of HDL-cholesterol into rat's primary hepatocyte via SR-B1.
2/2018	Secretion of GLP-1 but not GIP is potently stimulated by luminal d-Allulose (d-Psicose) in rats.
11/2017	d-Allulose enhances postprandial fat oxidation in healthy humans.
4/2017	Rare Sugar Syrup Containing d-Allulose but Not High-Fructose Corn Syrup Maintains Glucose Tolerance and Insulin Sensitivity Partly via Hepatic Glucokinase Translocation in Wistar Rats.
1/2017	Comparison of Anti-Obesity Effect between Two Types of Syrup Containing Rare Sugars in Wistar Rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuo Iida Research Topics

Disease

8	Body Weight (Weight, Body) 10/2021 - 02/2010
7	Obesity 01/2022 - 01/2013
4	Insulin Resistance 01/2022 - 04/2017
1	isovaleric Acidemia 05/2022
1	Fatigue 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Asthma (Bronchial Asthma) 09/2021
1	Diabetes Mellitus 01/2021
1	Atherosclerosis 04/2020
1	Glucose Intolerance 02/2018
1	Weight Gain 01/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2015
1	Diarrhea 01/2015
1	Metrorrhagia (Spotting) 12/2006

Drug/Important Bio-Agent (IBA)

13	psicose (D-psicose)IBA 01/2022 - 02/2010
5	SugarsIBA 05/2021 - 01/2015
4	Sucrose (Saccharose)IBA 09/2021 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2010
3	Sweetening Agents (Sweeteners)IBA 04/2020 - 01/2017
2	FructoseIBA 05/2021 - 11/2017
2	High Fructose Corn SyrupIBA 04/2017 - 06/2013
1	3-methylbutyrylcarnitineIBA 05/2022
1	pivaloylcarnitineIBA 05/2022
1	Indicators and Reagents (Reagents)IBA 05/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Pharmaceutical PreparationsIBA 09/2021
1	HDL CholesterolIBA 04/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2018
1	CarbohydratesIBA 11/2017
1	GlucokinaseIBA 04/2017
1	MonosaccharidesIBA 01/2017
1	EnzymesIBA 03/2014
1	Starch (Cornstarch)IBA 06/2013
1	Peptides (Polypeptides)IBA 12/2006
1	Biological ProductsIBA 12/2006